CANAURAL DIN 02427877
Status: Marketed
Holder: DECHRA VETERINARY PRODUCTS A/S
Molecule: DIETHANOLAMINE FUSIDATE
Available to quote
Health Canada record
| Active ingredient(s) | DIETHANOLAMINE FUSIDATE 5 MG; FRAMYCETIN SULFATE 5 MG; NYSTATIN 100000 UNIT; PREDNISOLONE 2.5 MG |
|---|---|
| Dosage form | Suspension |
| Route | Otic |
| Schedule | PRESCRIPTION |
| Class | Veterinary |
| ATC | |
| Original market date | 23-Jan-2015 |
| Current status date | 23-Jan-2015 |
| Source | Health Canada DPD |
Establishment licence of the holder
Dechra Veterinary Products Inc. — licence 102149, currently licensed, last inspection rating C (2025-05-13).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing DIETHANOLAMINE FUSIDATE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02277468 | CANAURAL | AVENTIX ANIMAL HEALTH CORP | Suspension | DIETHANOLAMINE FUSIDATE 5 MG; FRAMYCETIN SULFATE 5 MG; NYSTATIN 100000 UNIT; PREDNISOLONE 2.5 MG | Cancelled Post Market |
| 00727709 | CANAURAL (EAR DROPS) | LEO PHARMA INC | Suspension | DIETHANOLAMINE FUSIDATE 5 MG; FRAMYCETIN SULFATE 5 MG; NYSTATIN 100000 UNIT; PREDNISOLONE 2.5 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 29749 | 2022-12-22 | Supplement to a New Drug Submission (SNDS) | Addition of a drug substance manufacturing site |
| 28592 | 2022-07-14 | Supplement to a New Drug Submission (SNDS) | ADDITION OF DRUG SUBSTANCE MANUFACTURING SITE |
| 15813 | 2014-07-15 | New Drug Submission (NDS) | Administrative ¿ Change in product ownership |